The I-HEART Centre (Indigenous Health Education Access Research Training), in partnership with Boehringer Ingelheim (Canada) Ltd., and the University of British Columbia’s School of Kinesiology is proud to announce the $100,000 I-HEART Centre Indigenous Diabetes Management Scholarship, generously funded by Boehringer Ingelheim (Canada) Ltd.
“We are pleased to support the I-HEART Centre’s Indigenous Diabetes Management Scholarship in partnership with the University of British Columbia and the I-HEART Centre,” says Richard Mole, President and CEO, Boehringer Ingelheim (Canada) Ltd. “As an organization committed to investing in research that will ultimately lead to innovations in treatment, we hope that this program will lead to better health outcomes for Indigenous Canadians living with Type 2 diabetes.”
This academic scholarship will support research in the area of Indigenous Type 2 diabetes management for an academic student pursuing a post-doctoral training, enrolled at a Canadian University. The scholarship will go to a student whose research will help to better understand and promote how Indigenous people in Canada can be supported and educated around the management of Type 2 diabetes to better health outcomes. The scholarship is open to multidisciplinary approaches, and the funder will have no involvement or influence on the academic research process. The I-HEART Centre will promote the availability of this scholarship through connections with various academic institutions to find the most suitable candidate. “We’re most excited to partner with Boehringer Ingelheim (Canada) Ltd. to support innovative research regarding Type 2 diabetes in Indigenous Canadians,” says Robert Boushel, Director of UBC’s School of Kinesiology. “Our school is highly regarded for delivering excellent multidisciplinary research that promotes health and wellbeing, and this unique research opportunity reinforces this.”
Heart and vascular health of the indigenous population living with Type 2 diabetes is in crisis in Canada. A disproportionate number of Indigenous Canadians are living with Type 2 diabetes and its associated complications. Across the spectrum – from prevention to health services, treatment and care, research and surveillance – Indigenous people are underserviced in relation to the range and quality of programs available to alleviate the burdens posed by preventable heart, vascular brain, and cardiovascular illnesses. “I am thankful for the contribution made from Boehringer to support capacity building around Indigenous diabetes management and helping to close the gap to improve health outcomes of Indigenous Canadians,” says Dr. Jeff Reading the First Nations Health Authority Chair in Heart Health and Wellness based at St. Paul’s Hospital and Faculty of Health Sciences, Simon Fraser University.
For additional information and scholarship details, please contact Rebecca Lee, Research Manager, Programs and Strategic Planning, I-HEART Centre.
Deadline for submission: May 30, 2018 to UBC. Visit the HR website for tips on applying or view the job posting on our careers site.